Jiangsu Lianhuan Pharmaceutical (600513.SS) Earnings Analysis
Jiangsu Lianhuan Pharmaceutical (600513.SS) has no confirmed upcoming earnings date. Trailing P/E -41.05.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 600513.SS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 600513.SS. This page updates as the calendar is published.
600513.SS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2025-06-30 | -0.21887 CNY | n/a | n/a | n/a |
| 2025-03-31 | 0.08 CNY | n/a | n/a | n/a |
| 2024-12-31 | -0.02967 CNY | n/a | n/a | n/a |
600513.SS valuation and analyst view
| Trailing P/E | -41.05 |
|---|---|
| Trailing EPS | -0.35789 CNY |
| Price / book | 4.16 |
| Dividend yield | 0.42% |
| Market cap | 4.30B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Jiangsu Lianhuan Pharmaceutical (600513.SS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 600513.SS. This page updates as the calendar is published.
Did 600513.SS beat earnings last quarter?
Consensus estimate data was not available for 600513.SS's 2025-06-30 report.
What is 600513.SS's current P/E ratio and EPS?
600513.SS trades at a trailing P/E of -41.05 on trailing EPS of -0.3578886050961829 CNY.
What do analysts rate 600513.SS?
600513.SS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.